Literature DB >> 24878041

Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome.

Kristen Kobaly1, Priyathama Vellanki, Ryan K Sisk, Loren Armstrong, Ji Young Lee, Jungwha Lee, M Geoffrey Hayes, Margrit Urbanek, Richard S Legro, Andrea Dunaif.   

Abstract

CONTEXT: Polycystic ovary syndrome (PCOS) is a highly heritable complex trait. Parents of affected women have reproductive and metabolic phenotypes.
OBJECTIVE: We tested the hypothesis that there are parental effects on the heritability of fasting dysglycemia in women with PCOS. DESIGN AND
SETTING: This was a cross-sectional study at an academic medical center. PARTICIPANTS: PARTICIPANTS included 367 women with PCOS and their parents (1101 total subjects). MAIN OUTCOME MEASURES: We compared maternal and paternal contributions to heritability of fasting dysglycemia and to transmission of the PCOS susceptibility allele of D19S884 within the fibrillin-3 gene (D19S884-A8) on fasting dysglycemia.
RESULTS: Fathers had higher fasting glucose levels, prevalence of fasting dysglycemia and proinsulin to insulin molar ratios (P < .0001), a marker of defective insulin processing, compared with mothers. Heritability of fasting dysglycemia was significant in PCOS families (h(2) = 37%, SE = 10%, P = .001). Maternal heritability (h(2) = 51%, SE = 15%, P = .0009) was higher than paternal heritability (h(2) = 23 %, SE = 23%, P = .186) of fasting dysglycemia after adjustment for age and body mass index. Within dysglycemic probands, there was increased maternal compared with paternal transmission of D19S884-A8 (maternal 84% vs paternal 45%, χ(2) = 6.51, P = .011).
CONCLUSIONS: There was a sex difference in the parental metabolic phenotype with fathers having an increased risk of fasting dysglycemia and evidence for pancreatic β-cell dysfunction compared with mothers. However, only maternal heritability had significant effects on the prevalence of fasting dysglycemia in women with PCOS. Furthermore, there were maternal parent-of-origin effects on transmission of D19S884-A8 probands with fasting dysglycemia. These findings suggest that maternal factors, genetic and perhaps epigenetic, contribute to the metabolic phenotype in affected women.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24878041      PMCID: PMC4121025          DOI: 10.1210/jc.2013-4338

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

Review 1.  Heritability in the genomics era--concepts and misconceptions.

Authors:  Peter M Visscher; William G Hill; Naomi R Wray
Journal:  Nat Rev Genet       Date:  2008-03-04       Impact factor: 53.242

Review 2.  A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.

Authors:  C M Boomsma; M J C Eijkemans; E G Hughes; G H A Visser; B C J M Fauser; N S Macklon
Journal:  Hum Reprod Update       Date:  2006-08-04       Impact factor: 15.610

3.  Heritability of polycystic ovary syndrome in a Dutch twin-family study.

Authors:  J M Vink; S Sadrzadeh; C B Lambalk; D I Boomsma
Journal:  J Clin Endocrinol Metab       Date:  2005-10-11       Impact factor: 5.958

4.  Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.

Authors:  A Dunaif; K R Segal; W Futterweit; A Dobrjansky
Journal:  Diabetes       Date:  1989-09       Impact factor: 9.461

5.  Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.

Authors:  Bülent O Yildiz; Hakan Yarali; Havva Oguz; Miyase Bayraktar
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

6.  Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome.

Authors:  Susan Sam; Yeon-Ah Sung; Richard S Legro; Andrea Dunaif
Journal:  Metabolism       Date:  2008-01       Impact factor: 8.694

7.  Metabolic phenotype in the brothers of women with polycystic ovary syndrome.

Authors:  Susan Sam; Andrea D Coviello; Yeon-Ah Sung; Richard S Legro; Andrea Dunaif
Journal:  Diabetes Care       Date:  2008-03-10       Impact factor: 19.112

8.  Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype.

Authors:  Margrit Urbanek; Susan Sam; Richard S Legro; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2007-09-04       Impact factor: 5.958

9.  Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins.

Authors:  B Newman; J V Selby; M C King; C Slemenda; R Fabsitz; G D Friedman
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

Review 10.  Sex differences in the control of glucose homeostasis.

Authors:  Ellen Blaak
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-07       Impact factor: 4.294

View more
  9 in total

1.  Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity.

Authors:  Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

Review 2.  Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?

Authors:  Giovanni Targher; Maurizio Rossini; Amedeo Lonardo
Journal:  Endocrine       Date:  2015-05-30       Impact factor: 3.633

3.  Profile of Daughters and Sisters of Women With Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance.

Authors:  Soren Harnois-Leblanc; Maria Isabel Hernandez; Ethel Codner; Fernando Cassorla; Sharon E Oberfield; Natasha I Leibel; Revi P Mathew; Svetlana Ten; Denis A Magoffin; Christianne J Lane; Michael I Goran; Ricardo Azziz; Jean-Patrice Baillargeon; David H Geller
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

Review 4.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

Review 5.  Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.

Authors:  Manuel Luque-Ramírez; Héctor F Escobar-Morreale
Journal:  Curr Hypertens Rep       Date:  2014-12       Impact factor: 5.369

Review 6.  Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus.

Authors:  Alexandra Kautzky-Willer; Jürgen Harreiter; Giovanni Pacini
Journal:  Endocr Rev       Date:  2016-05-09       Impact factor: 19.871

Review 7.  Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology.

Authors:  Roshan Dadachanji; Nuzhat Shaikh; Srabani Mukherjee
Journal:  Genet Res Int       Date:  2018-02-18

Review 8.  The tempo of human childhood: a maternal foot on the accelerator, a paternal foot on the brake.

Authors:  Jennifer Kotler; David Haig
Journal:  Evol Anthropol       Date:  2018-03-25

Review 9.  Impact of Endocrine Disruptors upon Non-Genetic Inheritance.

Authors:  Debbie Montjean; Anne-Sophie Neyroud; Marina G Yefimova; Moncef Benkhalifa; Rosalie Cabry; Célia Ravel
Journal:  Int J Mol Sci       Date:  2022-03-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.